Patents by Inventor Bart Vanderborght

Bart Vanderborght has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV-3 retrovirus and its use
    Publication number: 20030039954
    Abstract: Described is a new variety of retrovirus designated HIV-3, also known as HIV-1 subtype O, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described is a process to detect the HIV-3 retrovirus in biological liquids or tissue. One such process involves contacting a biological sample suspected of containing HIV-3 nucleic acids with a DNA probe corresponding to a segment of genomic HIV-3 retrovirus RNA, such as the LTR region, and detecting the hybridization products thereof.
    Type: Application
    Filed: May 9, 2001
    Publication date: February 27, 2003
    Applicant: Innogenetics N.V.
    Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
  • HIV-3 retrovirus and its use
    Patent number: 6265200
    Abstract: Described is a new variety of retrovirus designated HIV-3, also known as HIV-1 subtype O, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are variants of the virus.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: July 24, 2001
    Assignee: Innogenetics N.V.
    Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
  • HIV-3 retrovirus and its use
    Patent number: 6013484
    Abstract: Described is a new variety of retrovirus designated HIV-3, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.
    Type: Grant
    Filed: July 25, 1997
    Date of Patent: January 11, 2000
    Assignee: Innogenetics N.V.
    Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
  • Methods for detecting antibodies against HIV-3 retrovirus ?and its use!
    Patent number: 5858647
    Abstract: Described is a new variety of retrovirus designated HIV-3, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. The methods to detect antibodies against HIV-3 retrovirus in a biological fluid involve contacting the suspect body fluid with a composition containing one or more of the proteins or glycoproteins of HIV-3 or with a lysate of the virus, or with an antigen possessing epitopes common to HIV-3, and detecting the immunological conjugate formed between the anti-HIV-3 antibodies and the antigen(s) used.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 12, 1999
    Assignee: Innogenetics N.V.
    Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
  • HIV-3 retrovirus antigen compositions
    Patent number: 5795743
    Abstract: Described is a new variety of retrovirus designated HIV-3 samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 18, 1998
    Assignee: Innogenetics N.V.
    Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
  • HIV-3 retrovirus and its use
    Patent number: 5567603
    Abstract: Described is a new retrovirus designated HIV-3, samples of which have been deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301.
    Type: Grant
    Filed: April 15, 1994
    Date of Patent: October 22, 1996
    Assignee: Innogenetics N.V.
    Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, Hugo Van Heuverswyn
  • HIV-3 retrovirus and its use
    Patent number: 5304466
    Abstract: Described is a new retrovirus designated HIV-3 and deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.
    Type: Grant
    Filed: March 23, 1990
    Date of Patent: April 19, 1994
    Assignee: Innogenetics N.V.
    Inventors: Robert De Leys, Bart Vanderborght, Eric Saman, H. Van Heuverswyn